Orchard Therapeutics plc
ORTX · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$150,660 | -$144,584 | -$151,979 | -$163,422 |
| Dep. & Amort. | $2,741 | $2,327 | $2,004 | $1,675 |
| Deferred Tax | -$3,283 | $1,131 | -$2,257 | -$6,390 |
| Stock-Based Comp. | $16,010 | $22,536 | $27,962 | $19,424 |
| Change in WC | $36,204 | -$17,063 | -$3,628 | -$17,729 |
| Other Non-Cash | $23,001 | $10,556 | $1,624 | $311 |
| Operating Cash Flow | -$75,987 | -$125,097 | -$126,274 | -$166,131 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$6,514 | -$3,235 | -$12,668 | -$4,367 |
| Net Acquisitions | $0 | $887 | $0 | $304,991 |
| Inv. Purchases | -$112,281 | -$263,878 | -$113,262 | -$414,010 |
| Inv. Sales/Matur. | $201,389 | $234,732 | $281,433 | $109,019 |
| Other Inv. Act. | $7,966 | -$671 | $1,876 | -$304,991 |
| Investing Cash Flow | $90,560 | -$32,165 | $157,379 | -$309,358 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $154,135 | $0 | $130,270 |
| Stock Repurch. | -$19 | -$392 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$693 | $158,066 | $3,936 | $157,453 |
| Financing Cash Flow | -$693 | $158,066 | $3,936 | $157,453 |
| Forex Effect | -$1,419 | -$27 | $1,043 | $1,672 |
| Net Chg. in Cash | $12,461 | $777 | $36,084 | -$316,364 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $60,178 | $59,401 | $23,317 | $339,681 |
| End Cash | $72,639 | $60,178 | $59,401 | $23,317 |
| Free Cash Flow | -$82,501 | -$128,332 | -$138,942 | -$170,498 |